- Home
- PGY vs EYPT Comparison
PGY vs EYPT Comparison
Compare PGY & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGY
- EYPT
- Stock Information
- Founded
- PGY 2016
- EYPT 1987
- Country
- PGY United States
- EYPT United States
- Employees
- PGY N/A
- EYPT N/A
- Industry
- PGY Finance: Consumer Services
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- PGY Finance
- EYPT Industrials
- Exchange
- PGY Nasdaq
- EYPT Nasdaq
- Market Cap
- PGY 707.8M
- EYPT 594.5M
- IPO Year
- PGY N/A
- EYPT 2005
- Fundamental
- Price
- PGY $8.78
- EYPT $7.48
- Analyst Decision
- PGY Buy
- EYPT Strong Buy
- Analyst Count
- PGY 8
- EYPT 8
- Target Price
- PGY $21.00
- EYPT $25.71
- AVG Volume (30 Days)
- PGY 1.7M
- EYPT 922.9K
- Earning Date
- PGY 02-19-2025
- EYPT 03-06-2025
- Dividend Yield
- PGY N/A
- EYPT N/A
- EPS Growth
- PGY N/A
- EYPT N/A
- EPS
- PGY N/A
- EYPT N/A
- Revenue
- PGY $970,898,000.00
- EYPT $45,713,000.00
- Revenue This Year
- PGY $26.59
- EYPT N/A
- Revenue Next Year
- PGY $14.40
- EYPT N/A
- P/E Ratio
- PGY N/A
- EYPT N/A
- Revenue Growth
- PGY 23.38
- EYPT 7.50
- 52 Week Low
- PGY $8.20
- EYPT $6.90
- 52 Week High
- PGY $20.00
- EYPT $30.99
- Technical
- Relative Strength Index (RSI)
- PGY 42.09
- EYPT 44.49
- Support Level
- PGY $8.27
- EYPT $7.15
- Resistance Level
- PGY $9.23
- EYPT $8.25
- Average True Range (ATR)
- PGY 0.63
- EYPT 0.66
- MACD
- PGY -0.05
- EYPT -0.01
- Stochastic Oscillator
- PGY 19.39
- EYPT 22.01
About PGY Pagaya Technologies Ltd.
Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, big data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.